Results 31 to 40 of about 13,791 (225)

Imatinib Mesylate Reduces Neurotrophic Factors and pERK and pAKT Expression in Urinary Bladder of Female Mice With Cyclophosphamide-Induced Cystitis

Frontiers in Systems Neuroscience, 2022
Imatinib mesylate is a tyrosine kinase inhibitor that inhibits platelet-derived growth factor receptor (PDGFR)-α, -β, stem cell factor receptor (c-KIT), and BCR-ABL.
Megan Perkins, Beatrice M. Girard, Susan E. Campbell, Grant W. Hennig, Margaret A. Vizzard   +4 more
doaj   +1 more source

Association of dysmenorrhea with interstitial cystitis/bladder pain syndrome: a case-control study

, 2017
Objective. Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic disabling condition of the urological system. Many gynecological conditions are reported to be associated with IC/BPS. This study presents epidemiological evidence of a possible
Chung, Shiu-Dong;Liu, Shih-Ping;Lin, Herng-Ching;Kang, Jiunn-Horng, 劉詩彬   +1 more
core   +1 more source

Gut microbiota and interstitial cystitis: exploring the gut-bladder axis through mendelian randomization, biological annotation and bulk RNA sequencing

Frontiers in Immunology
BackgroundSeveral observational studies have indicated an association between interstitial cystitis and the composition of the gut microbiota; however, the causality and underlying mechanisms remain unclear.
Chaowei Fu, Yu Zhao, Xiang Zhou, Jing Lv, Shengkai Jin, Yuhua Zhou, Fengping Liu, Ninghan Feng, Ninghan Feng   +8 more
doaj   +1 more source

Urinary Levels of Substance P and its Metabolites are not Increased in Interstitial Cystitis

, 2001
Objectives: To determine whether interstitial cystitis is associated with the increased release of substance P from the bladder wall into urine, by measuring urinary excretion rates of substance P and its metabolites in women with interstitial cystitis ...
N. Tenis, Tenis, N., Clements, Judith, Dwyer, P. L., Campbell, D, A. Rosamilia, P.L. Dwyer, J.A. Clements, Rosmilia, A, D.J. Campbell   +9 more
core   +1 more source

Statin Use Is Associated with Bladder Pain Syndrome/Interstitial Cystitis: A Population-Based Case-Control Study

, 2017
Introduction: Statin may induce epithelial dysfunction of the bladder urothelium. Epithelial dysfunction was proposed as one of the major potential etiologies for bladder pain syndrome/interstitial cystitis (BPS/IC).
黃昭淵, Huang, C. Y.;Chung, S. D.;Kao, L. T.;Lin, H. C.;Wang, L. H.   +1 more
core   +1 more source

Understanding mechanisms of Ketamine-induced human urinary tract damage [PDF]

, 2011
Ketamine is a phencyclidine derivative N-Methyl D-Aspartate (NMDA) receptor antagonist used as an anaesthetic and analgesic. A florid non-bacterial cystitis condition known as ketamine-induced cystitis (KIC) has recently been reported in abusers and ...
Shahzad, Khurram
core  

Botulinum Toxin A for Bladder Pain Syndrome/Interstitial Cystitis

, 2017
Botulinum neurotoxin A (BoNT-A), derived from Clostridium botulinum, has been used clinically for several diseases or syndrome including chronic migraine, spasticity, focal dystonia and other neuropathic pain. Chronic pelvic or bladder pain is the one of
Chiu, Bin;Tai, Huai-Ching;Chung, Shiu-Dong;Birder, Lori A., 戴槐青   +1 more
core   +1 more source

Pathology of interstitial cystitis [PDF]

International Journal of Urology, 2003
Abstract In this workshop the participants were asked to consider the role of pathology in the diagnosis and management of interstitial cystitis (IC). Currently, the NIDDK definition of IC is made on clinical criteria; bladder biopsy is not required for the clinical work‐up and histology is not used as a diagnostic criterion.
Anna, Rosamilia, Yasuhiko, Igawa, Shin, Higashi   +2 more
openaire   +2 more sources

Evaluating the Evolving Real‐World Adverse Events of GLP‐1RAs Using FDA Adverse Event Reporting System (FAERS)

Obesity, EarlyView.
Web portal for interrogating Adverse Events of GLP‐1 RA in diabetes vs weight control/obesity. ABSTRACT Objective This study aimed to assess the spectrum and frequency of adverse events (AEs) linked to glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) using the US FDA Adverse Event Reporting System (FAERS).
David Stone, Mary Playdon, Stephen D. Hursting, Aik Choon Tan   +3 more
wiley   +1 more source

Participação dos receptores CXCR2 e TRPV1 na cistite induzida por ciclofosfamida em ratos [PDF]

, 2013
Tese (doutorado) - Universidade Federal de Santa Catarina, Centro de Ciências Biológicas, Programa de Pós-Graduação em Farmacologia, Florianópolis, 2013.A proposta do presente estudo foi avaliar a participação dos receptores CXCR2 e TRPV1 na cistite ...
Dornelles, Fabiana Noronha
core